All In Biotech

Free tool

FAERS Monitor: Varubi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206500 or its brand name (Varubi, Rolapitant Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

539

Serious

418

78% of reports

Hospitalization

115

Death reported

164

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death143
  • nausea79
  • fatigue51
  • infusion related reaction40
  • dyspnoea34
  • decreased appetite33
  • flushing32
  • diarrhoea30
  • thrombocytopenia29
  • dehydration22
  • vomiting22
  • chest discomfort21
  • anaemia20
  • back pain19
  • weight decreased17

Reports by year received

View as table
YearReports
201317
20141
20151
201694
2017111
201896
201960
2020116
202118
20224
20234
20247
20253
20267

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,620 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal4023.617.5844
flushingSignal3212.38.8322
thrombocytopeniaSignal2910.17.1231
chest discomfortSignal218.05.3122
deathSignal1436.55.6685
dehydrationSignal226.44.396
decreased appetiteSignal335.54.0120
anaemiaSignal204.12.744
nauseaSignal793.93.2174
back painSignal193.22.127
fatigueSignal512.62.049
weight decreasedSignal172.41.512
dyspnoeaSignal342.31.726
vomiting221.81.28
diarrhoea301.81.310

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.